Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hilary A. Chaudri
Letrozole (CGS 20267), a New Oral Aromatase Inhibitor for the Treatment of Advanced Breast Cancer in Postmenopausal Patients
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Related publications
Anastrozole as Aromatase Inhibitor – New Approaches to Breast Cancer Treatment in Postmenopausal Women
Nowotwory
Cancer Research
Oncology
Deficiencies in Immunoassay Methods Used to Monitor Serum Estradiol Levels During Aromatase Inhibitor Treatment in Postmenopausal Breast Cancer Patients
SpringerPlus
Multidisciplinary
Sequential Changes in Gene Expression Profiles in Breast Cancers During Treatment With the Aromatase Inhibitor, Letrozole
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Combination of Aromatase Inhibitors With Metronomic Capecitabine: A New Chemoendocrine Treatment for Advanced Breast Cancer
Journal of Cancer Therapy
Accumulation of P53 Is Prognostic for Aromatase Inhibitor Resistance in Early-Stage Postmenopausal Patients With ER-positive Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor
Breast Care
Surgery
Oncology
Efficacy of Adjuvant Aromatase Inhibitor in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients According to the Body Mass Index
British Journal of Cancer
Cancer Research
Oncology
Review of Hormone-Based Treatments in Postmenopausal Patients With Advanced Breast Cancer Focusing on Aromatase Inhibitors and Fulvestrant
ESMO Open
Cancer Research
Oncology
(557) Auricular Point Acupressure to Manage Aromatase Inhibitor-Induced Arthralgia in Postmenopausal Breast Cancer Survivors
Journal of Pain
Neurology
Anesthesiology
Pain Medicine
